Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
-0.26%
N225
+0.06%
AXJO
+0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
204.43B
Dividend Yield
0.00%
P/E Ratio
11.73
EPS
6.76
Revenue
64.17B
Avg. Volume
13.73M

Recently from Cashu

publisher logo
Cashu

Merck & Co. Gains FDA Priority Review for Winrevair, Transforming Patient Care Potential

1 day ago
publisher logo
Cashu

Merck & Co's Enflonsia Approved for RSV Prevention in Infants Under 8 Months

4 days ago
publisher logo
Cashu

Merck & Co. Gains ACIP Approval for Enflonsia, Advancing RSV Prevention in Infants

5 days ago

About

What does MRK do?
Merck & Co., headquartered in Rahway, New Jersey, employs 72,000 people and provides health solutions through pharmaceuticals, vaccines, and animal health products. Its lead candidate is MK-6070, targeting DLL3.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New Jersey, USA
Website
http://www.merck.com
Stocks
Health Care
mrk
Merck & Co
MRK
-1.43 (-1.74%)
80.96
USD
At close at Jul 03, 20:34 UTC
Summary
News
Signals
Benchmarks
Financials